INDAPTA THERAPEUTICS INC

From the company

Indapta Therapeutics is a biotechnology company focused on developing and commercializing a proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat cancer and autoimmune diseases. Its platform is based on a naturally occurring subset of NK cells deficient in the FceR1g protein, derived from healthy donors. The company is based in Houston, TX, and Seattle, WA.